Alibek Kenneth B, Ponomarev Igor A, Myrzaliyeva Dana B, Aituov Bauyrzhan A, Zhussupbekova Samal K, Sypabekova Marzhan D and Bekmurzayeva Aliya K
Objectives: Current breast cancer treatment involves both standard (e.g., surgery, chemotherapy radiation therapy, and hormone therapy) and new immune therapy methods. Standard treatments are effective at early stages but their effectiveness drops with advanced stages. Recent studies suggest that bacterial and viral infection could be implicated in breast cancer pathogenesis. Therefore, pathogenic inhibition could be a feasible treatment approach. A 54-year-old woman presented with an inflammatory-edematous form of breast cancer (T4N1M1 stage). Due to the inflammatory edematous form tumor was fully metastasized and inoperable. Patients with similar condition usually have a very short life span. Methods: This patient underwent a combinatorial therapy consisting of immunocorrective and metabolism regulating therapy, as well as antimicrobial and standard chemotherapy. Results: This treatment was shown to extend patient’s life for almost two additional years. This case report demonstrates extent and possibility of using a systemic approach to treat inoperable breast cancer.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 